Showing results (51-60 of 65) with videos related to
Sort By:
Pageof 7
Pharmacological Research|January 13, 2017
Anaplastic lymphoma kinase (ALK) inhibitors in the treatment of ALK-driven lung cancersRobert RoskoskiPharmacological Research|November 4, 2015
Classification of small molecule protein kinase inhibitors based upon the structures of their drug-enzyme complexesRobert RoskoskiPharmacological Research|January 12, 2021
Orally effective FDA-approved protein kinase targeted covalent inhibitors (TCIs)Robert RoskoskiPharmacological Research|August 18, 2018
Targeting oncogenic Raf protein-serine/threonine kinases in human cancersRobert RoskoskiPharmacological Research|March 28, 2021
Properties of FDA-approved small molecule phosphatidylinositol 3-kinase inhibitors prescribed for the treatment of malignanciesRobert RoskoskiPharmacological Research|February 10, 2015
Src protein-tyrosine kinase structure, mechanism, and small molecule inhibitorsRobert RoskoskiPharmacological Research|June 15, 2014
ErbB/HER protein-tyrosine kinases: Structures and small molecule inhibitorsRobert RoskoskiAcademic Medicine : Journal of the Association of American Medical Colleges|November 10, 2022
Trends in NIH Funding to Medical Schools in 2011 and 2020Robert RoskoskiPharmacological Research|August 27, 2021
Blockade of mutant RAS oncogenic signaling with a special emphasis on KRASRobert RoskoskiPharmacological Research|December 14, 2023
Cost in the United States of FDA-approved small molecule protein kinase inhibitors used in the treatment of neoplastic and non-neoplastic diseasesRobert RoskoskiPageof 7